(Q37282700)

19 August 2017

Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans (English)

1 reference

19 August 2017

1 reference

1 reference

1

Tom van der Poll

1 reference

19 August 2017

Marcel Levi

2

1 reference

19 August 2017

Jerry A Nick

series ordinal

3

1 reference

19 August 2017

Edward Abraham

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

4 March 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

19 August 2017

1 reference

19 August 2017

171

1 reference

19 August 2017

10

1 reference

19 August 2017

1125-1128

1 reference

Protective role of activated protein C in lung and airway remodeling.

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Activated protein C in sepsis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Efficacy and safety of recombinant human activated protein C for severe sepsis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Protein C and thrombomodulin in human acute lung injury

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Local inflammatory responses following bronchial endotoxin instillation in humans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Fibrinolytic response to tumor necrosis factor in healthy subjects

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

A novel functional assay of protein C in human plasma and its comparison with amidolytic and anticoagulant assays

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Effects of drotrecogin alfa (activated) in human endotoxemia.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718442

3 September 2018

The Protein C Pathway

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.200411-1483OC

Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients

21 January 2018

1 reference

12 December 2020

A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation

1 reference

12 December 2020

Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia

1 reference

12 December 2020

Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis

1 reference

12 December 2020

A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma

1 reference

12 December 2020

The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency

1 reference

12 December 2020

Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma

1 reference

12 December 2020

Quantitation of urokinase antigen in plasma and culture media by use of an ELISA

1 reference

12 December 2020

Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor

1 reference

12 December 2020

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

1 reference

12 December 2020

Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit

1 reference

12 December 2020

Protein C, protein S and C4b-binding protein in severe infection and septic shock

1 reference

12 December 2020

Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis

1 reference

12 December 2020

Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock

1 reference

12 December 2020

Increased circulating thrombomodulin in children with septic shock

1 reference

12 December 2020

Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis

1 reference

12 December 2020

Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia

1 reference

12 December 2020

Coagulation abnormalities in acute lung injury and sepsis

1 reference

12 December 2020

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

1 reference

12 December 2020

10.1164/RCCM.200411-1483OC

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference